Tax information for the 2016 tax year is coming soon. Please check back.
Optimum Fund Trust capital gains estimates
Frequently asked questions
While preparing your taxes you may have a number of questions. Delaware Investments provides answers to some frequently asked questions regarding distributions, including dividends and capital gains distributions.
Funds that derived income from U.S. government obligations
In most states, income from U.S. Treasury securities and other direct U.S. government obligations generally is exempt from state income taxes subject, in some states, to minimum investment or reporting requirements that must be met by a fund. Please contact your tax advisor for details. See the list of Optimum Funds and the percentage of ordinary dividends they derived from U.S. government obligations.
Foreign tax — for shareholders of international funds
Shareholders of certain international funds may be able to reduce their 2015 income taxes in connection with foreign income tax paid by those funds.
The information contained in this section is not intended to be legal or tax advice. If you need assistance preparing your tax return, please consult a tax advisor.
Information may be abridged and therefore incomplete. Any discussion pertaining to taxes in this communication (including attachments) may be part of the promotion or marketing of a product. Advice (if any) related to federal taxes that is contained in this communication (including attachments) is not intended or written to be used, and cannot be used, for the purpose of avoiding penalties under the Internal Revenue Code. Individuals should seek advice based on their own particular circumstances from an independent tax advisor.
Investing involves risk, including the possible loss of principal.
Carefully consider the Fund’s investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Fund’s prospectus and, if available, its summary prospectus, which may be obtained by visiting the fund literature page or calling 800 914-0278. Investors should read the prospectus and, if available, the summary prospectus carefully before investing.